s6y
Company name or ticker
Search
Nautilus Biotechnology, Inc.
3
Akinsanya Karen: Initial statement of beneficial ownership of securities
Filed
Thursday, March 31, 2022
Period
Mar 30, 2022
Accession number
0001808805-22-000031
Documents
FORM 3
3
KAREN AKINSANYA POA
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header